National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

Read this book online, free! Click here to proceed to linked table of contents

Improving the Quality of Cancer Clinical Trials:

Workshop Summary

Book Cover

Status: Available Now

Size: 136 pages, 6 x 9

Publication Year:2008


E-mail this page
Print List Price    
Order online and save 10%
PAPERBACK
ISBN-10: 0-309-11668-6
ISBN-13: 978-0-309-11668-8
$33.75   Add to Cart
PDF     About PDF

Authors:
Margie Patlak and Sharyl Nass, Rapporteurs
Authoring Organizations

Description:
Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ...
Read More


Paste into your Web page:

Preview
Free Resources
Read

Full Text
Jump to this book's table of contents to begin reading online for free.

Research Tools
Download Free
No free downloads available for this title.
Rights & Permissions

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Description

Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: (1) better inform decisions and plans of those responsible for developing new cancer therapies (2) more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic (3) be less costly than current trials The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward.

Search This Book

»Find more like this book

SIGN UP FOR...

New Title Emails
Read about the newest releases and receive special offers.